Pure mitochondrial myopathy

Pure mitochondrial myopathy is a rare genetic muscle disorder characterized by skeletal muscle dysfunction caused by defects in mitochondrial function, without significant involvement of other organ systems. Unlike many mitochondrial disorders that affect multiple tissues (such as the brain, heart, or eyes), pure mitochondrial myopathy predominantly affects skeletal muscle. The condition results from impaired oxidative phosphorylation within muscle mitochondria, leading to insufficient energy production for normal muscle function. Key clinical features include exercise intolerance, progressive muscle weakness (particularly of proximal muscles), fatigue, and myalgia. Patients may experience difficulty with activities such as climbing stairs, lifting objects, or sustained physical exertion. Muscle biopsy typically reveals characteristic findings such as ragged-red fibers, cytochrome c oxidase (COX)-negative fibers, and abnormal mitochondrial proliferation. Elevated serum lactate levels may be observed, particularly after exercise. The severity and age of onset can vary considerably depending on the underlying genetic defect. Pure mitochondrial myopathy can be caused by mutations in mitochondrial DNA (mtDNA) or nuclear DNA genes encoding mitochondrial proteins. There is currently no curative treatment. Management is primarily supportive and includes graded aerobic exercise programs, which have been shown to improve exercise capacity, as well as nutritional supplementation (such as coenzyme Q10, L-carnitine, and B vitamins), though evidence for their efficacy remains limited. Avoidance of mitochondrial toxins, management of symptoms, and regular monitoring by a multidisciplinary team are recommended.

Common questions about Pure mitochondrial myopathy